Align Technology
ALIGN TECHNOLOGY, INC.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$4.0B
Operating marginCalculated
13.5%
Net assets to total assetsCalculated
65.0%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★★★☆position among all companies
13.5%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
0.5%
Capital efficiency
★★★☆☆position among all companies
10.1%
Revenue and profit
Performance, financial position and capital allocation
Align Technology
Recent performance trends
Align Technology
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$4.0 billion | US$3.7 billion | US$3.9 billion | US$4.0 billion | US$4.0 billion |
| Operating income | US$1.0 billion | US$0.6 billion | US$0.6 billion | US$0.6 billion | US$0.5 billion |
| Net income | US$0.8 billion | US$0.4 billion | US$0.4 billion | US$0.4 billion | US$0.4 billion |
| Total assets | US$5.9 billion | US$5.9 billion | US$6.1 billion | US$6.2 billion | US$6.2 billion |
| Shareholders' equity | US$3.6 billion | US$3.6 billion | US$3.6 billion | US$3.9 billion | US$4.0 billion |
| Net cash provided by (used in) operating activities | US$1.2 billion | US$0.6 billion | US$0.8 billion | US$0.7 billion | US$0.6 billion |
| Net cash provided by (used in) investing activities | US$-0.6 billion | US$-0.2 billion | US$-0.2 billion | US$-0.3 billion | US$-0.1 billion |
| Net cash provided by (used in) financing activities | US$-0.5 billion | US$-0.5 billion | US$-0.6 billion | US$-0.4 billion | US$-0.5 billion |
| Cash and cash equivalents | US$1.1 billion | US$0.9 billion | US$0.9 billion | US$1.0 billion | US$1.1 billion |
Revenue scale in the same industry
Align Technology
Instruments and medical devices: 43 companies · revenue · largest first・each company’s latest fiscal year・Consolidated・Disclosed
- 1 Thermo Fisher ScientificFY Dec 2025 US$44.6B
- 2 Northrop Grumman Corp /DE/FY Dec 2025 US$42.0B
- 3 MedtronicFY Apr 2026 US$36.4B
- … 28 companies
- 32 HologicFY Sep 2025 US$4.1B
- 33 The Cooper CompaniesFY Oct 2025 US$4.1B
- 34 Align TechnologyThis companyFY Dec 2025 US$4.0B
- 35 Mettler-Toledo InternationalFY Dec 2025 US$4.0B
- 36 MKSFY Dec 2025 US$3.9B
- … 7 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Purchase of property, plant and equipment | US$0.1 billion | Consolidated | Disclosed |
| Cash and cash equivalents | US$1.1 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$-0.5 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-0.1 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$0.6 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.2 billion | Consolidated | Disclosed |
| Net assets | US$4.0 billion | Consolidated | Disclosed |
| Net sales | US$4.0 billion | Consolidated | Disclosed |
| Operating income | US$0.5 billion | Consolidated | Disclosed |
| Net income | US$0.4 billion | Consolidated | Disclosed |
| Total assets | US$6.2 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$0.5 billion | Consolidated | Disclosed |
| Operating margin | 13.5% | Consolidated | Calculated |
| Net assets to total assets | 65.0% | Consolidated | Calculated |
| Net margin | 10.2% | Consolidated | Calculated |
| Return on equity | 10.1% | Consolidated | Calculated |